Last reviewed · How we verify
NCT01637688: CMPA
Growth and Plasma Amino Acids in Infants With CMPA and Treated With a Newly Innovated Amino Acid Formula
trial testing Comparison of treatment with different amino acid formulas in Cow Milk Allergy in 81 participants. Status unknown.
30 June 2023
Quick facts
| Lead sponsor | Mahidol University |
|---|---|
| Status | Status unknown |
| Study type | OBSERVATIONAL |
| Enrollment | 81 |
| Start date | 1 April 2013 |
| Primary completion | 30 June 2023 |
| Estimated completion | 31 July 2023 |
| Sites | 1 location across Thailand |
Drugs / interventions tested
- Comparison of treatment with different amino acid formulas
Conditions studied
- Cow Milk Allergy — all drugs for Cow Milk Allergy →
Sponsor
Mahidol University
Who can join
Adults 1 Week to 6 Months, any sex, with Cow Milk Allergy. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of this study is to determine growth and protein status of infants with cow's milk protein allergy and treated with a newly innovated amino acid formula compared to those with a commercial amino acid formula.
Publications & conference data
No peer-reviewed publications indexed yet for this trial.
Verify or expand the search:
- PubMed search for NCT01637688
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Cow Milk Allergy
Currently open trials in the same condition.
- NCT06380673 — Stepwise Heat-Denaturated Protein Introduction for Tolerance Induction in Food Allergy · NA · recruiting
- NCT05785299 — Clinical Versus Home Introduction of Milk in Children with Non-IgE-mediated Cow's Milk Allergy · NA · recruiting
- NCT04249973 — Detection of Metabolite Biomarkers for the Early Diagnosis and Prognosis of Cow's Milk Allergy in Children · active not recruiting
Other Mahidol University trials
Trials by the same sponsor.
- NCT07568496 — Greater Occipital Nerve Block for Migraine With Medication Overuse Headache · NA · not yet recruiting
- NCT07407400 — Lemborexant for Sleep and Delirium Prevention in Elderly ICU Patients · Phase 4 · not yet recruiting
- NCT07378501 — Thai Version of the Pediatric Quality of Recovery Score (PedSQoR): Translation and Psychometric Validation Study · not yet recruiting
- NCT07438301 — Septic Shock Hemodynamic Respond to Volume Resuscitation Versus Vasopressor Administration · not yet recruiting
- NCT07390006 — Enabling Patient-Reported Outcomes Through Innovative Care - ACS (EPIC-ACS) · NA · not yet recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT01637688 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Mahidol University
- Last refreshed: 24 March 2023
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT01637688.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing